Nicolas Kozakowski
Overview
Explore the profile of Nicolas Kozakowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
973
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paschen C, Koeller M, Schachner H, Nackenhorst M, Klager J, Oszwald A, et al.
Hypertension
. 2025 Mar;
PMID: 40047102
Background: Arterial hypertension (HTN) and type 2 diabetes (T2DM) are contributors to chronic kidney disease leading to glomerulomegaly and podocyte loss. Enlarged glomeruli and podocyte depletion are associated with kidney...
2.
Kozakowski N, Agis H, Krauth M, Simonitsch-Klupp I, Schiefer A, Grunberger B, et al.
Kidney Int Rep
. 2025 Jan;
10(1):256-259.
PMID: 39810789
No abstract available.
3.
Aigner C, Gaggl M, Schmidt S, Kain R, Kozakowski N, Oszwald A, et al.
Kidney Blood Press Res
. 2024 Oct;
49(1):970-977.
PMID: 39437764
Introduction: The coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus is alleged to enable a proinflammatory state that leads to the activation...
4.
Omic H, Eder M, Schrag T, Kozakowski N, Klager J, Bond G, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407774
Polyomavirus-associated nephropathy (BKPyVAN) is a common complication in kidney transplant recipients. The histological changes in the context of BKPyVAN and their association with the viral load and outcomes are still...
5.
Diebold M, Mayer K, Hidalgo L, Kozakowski N, Budde K, Bohmig G
Transplantation
. 2024 Aug;
PMID: 39192468
In kidney transplantation, ongoing alloimmune processes-commonly triggered by HLA incompatibilities-can trigger chronic transplant rejection, affecting the microcirculation and the tubulointerstitium. Continuous inflammation may lead to progressive, irreversible graft injury, culminating...
6.
Diebold M, Farkash E, Barnes J, Regele H, Kozakowski N, Schatzl M, et al.
Transpl Int
. 2024 Jul;
37:13209.
PMID: 38979120
Transcript analyses highlight an important contribution of natural killer (NK) cells to microvascular inflammation (MVI) in antibody-mediated rejection (ABMR), but only few immunohistologic studies have quantified their spatial distribution within...
7.
Eder M, Schrag T, Havel E, Kainz A, Omic H, Doberer K, et al.
Kidney Int Rep
. 2024 Jun;
9(6):1730-1741.
PMID: 38899213
Introduction: Earlier reports suggest that patients after ABO-incompatible kidney transplantation (ABOi) are at enhanced risk of developing BK-virus (BKV, also known as BK polyomavirus [BKPyV]) nephropathy (BKPyVAN). It remains elusive...
8.
Rabant M, Adam B, Aubert O, Bohmig G, Clahsen Van-Groningen M, Cornell L, et al.
Transplantation
. 2024 Jun;
109(2):292-299.
PMID: 38886879
In September 2022, in Banff, Alberta, Canada, the XVIth Banff meeting, corresponding to the 30th anniversary of the Banff classification, was held, leading to 2 recent publications. Discussions at the...
9.
Mayer K, Schrezenmeier E, Diebold M, Halloran P, Schatzl M, Schranz S, et al.
N Engl J Med
. 2024 May;
391(2):122-132.
PMID: 38804514
Background: Antibody-mediated rejection is a leading cause of kidney-transplant failure. The targeting of CD38 to inhibit graft injury caused by alloantibodies and natural killer (NK) cells may be a therapeutic...
10.
Kozakowski N
Pathologie (Heidelb)
. 2024 Apr;
45(4):269-276.
PMID: 38649466
Background: The Banff Foundation produces recommendations for classifying various lesions in renal allografts. Experts gather to update the classification every other year based on new scientific and clinical evidence. Objectives:...